Theravance Biopharma Inc (TBPH)
Retained Earnings
-$870.46M
Quarterly · Period ending: · USD
TBPH Retained Earnings
Latest reported-$870.46Mperiod ending
Latest reported-$870.46Mperiod ending
TBPH Quarterly Retained Earnings (-$6.99M → -$870.46M)
Quarterly retained earnings
High-resolution chart · PNG
TBPH retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -870,458,000 | |
| -864,560,000 | |
| -859,627,000 | |
| -920,651,000 | |
| -924,266,000 | |
| -979,101,000 | |
| -965,522,000 | |
| -949,995,000 | |
| -937,297,000 | |
| -920,768,000 | |
| -909,104,000 | |
| -900,594,000 | |
| -891,644,000 | |
| -875,999,000 | |
| -853,911,000 | |
| -843,549,000 | |
| -1,760,180,000 | |
| -1,751,989,000 | |
| -1,726,043,000 | |
| -1,694,009,000 | |
| -1,658,701,000 | |
| -1,606,296,000 | |
| -1,526,617,000 | |
| -1,468,183,000 | |
| -1,394,540,000 | |
| -1,331,653,000 | |
| -1,248,600,000 | |
| -1,182,994,000 | |
| -1,124,563,000 | |
| -1,084,725,000 | |
| -1,012,145,000 | |
| -961,959,000 | |
| -902,526,000 | |
| -861,708,000 | |
| -797,740,000 | |
| -710,818,000 | |
| -643,941,000 | |
| -577,654,000 | |
| -512,225,000 | |
| -444,892,000 | |
| -410,931,000 | |
| -363,706,000 | |
| -321,556,000 | |
| -276,730,000 | |
| -229,415,000 | |
| -181,811,000 | |
| -139,337,000 | |
| -75,027,000 | |
| -20,532,000 | |
| -17,916,000 | |
| -17,035,000 | |
| -14,367,000 | |
| -12,056,000 | |
| -4,375,000 | |
| -6,990,000 |